BR9408335A - Composto uso do mesmo e composição farmacêutica - Google Patents

Composto uso do mesmo e composição farmacêutica

Info

Publication number
BR9408335A
BR9408335A BR9408335A BR9408335A BR9408335A BR 9408335 A BR9408335 A BR 9408335A BR 9408335 A BR9408335 A BR 9408335A BR 9408335 A BR9408335 A BR 9408335A BR 9408335 A BR9408335 A BR 9408335A
Authority
BR
Brazil
Prior art keywords
unsubstituted
alkanyl
alkenyl
compounds
same
Prior art date
Application number
BR9408335A
Other languages
English (en)
Inventor
Thomas Lee Cupps
Peter Julian Muerer
Jeffrey Joseph Ares
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/326,564 external-priority patent/US5578607A/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9408335A publication Critical patent/BR9408335A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9408335A 1993-12-17 1994-12-15 Composto uso do mesmo e composição farmacêutica BR9408335A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16934393A 1993-12-17 1993-12-17
US08/326,564 US5578607A (en) 1993-12-17 1994-10-20 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
PCT/US1994/014293 WO1995016683A1 (en) 1993-12-17 1994-12-15 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists

Publications (1)

Publication Number Publication Date
BR9408335A true BR9408335A (pt) 1997-08-19

Family

ID=26864975

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9408335A BR9408335A (pt) 1993-12-17 1994-12-15 Composto uso do mesmo e composição farmacêutica

Country Status (22)

Country Link
US (1) US5739148A (pt)
EP (1) EP0736020B1 (pt)
JP (1) JPH09511483A (pt)
CN (1) CN1046718C (pt)
AT (1) ATE192150T1 (pt)
AU (1) AU699041B2 (pt)
BR (1) BR9408335A (pt)
CA (1) CA2179264C (pt)
CZ (1) CZ285481B6 (pt)
DE (1) DE69424183T2 (pt)
DK (1) DK0736020T3 (pt)
ES (1) ES2146307T3 (pt)
FI (1) FI962491A7 (pt)
GR (1) GR3033515T3 (pt)
HU (1) HU217841B (pt)
NO (1) NO308662B1 (pt)
NZ (1) NZ333370A (pt)
PL (1) PL180392B1 (pt)
PT (1) PT736020E (pt)
SG (1) SG55141A1 (pt)
SK (1) SK77096A3 (pt)
WO (1) WO1995016683A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW527355B (en) * 1997-07-02 2003-04-11 Bristol Myers Squibb Co Inhibitors of farnesyl protein transferase
US20070293539A1 (en) * 2004-03-18 2007-12-20 Lansbury Peter T Methods for the treatment of synucleinopathies
US20060106060A1 (en) * 2004-03-18 2006-05-18 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies (Lansbury)
WO2005089515A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
JP2007529555A (ja) * 2004-03-18 2007-10-25 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド シヌクレイノパチーを治療する方法
EP1744751A4 (en) * 2004-03-18 2010-03-10 Brigham & Womens Hospital METHOD FOR THE TREATMENT OF SYNUCLEINOPATHIES
ATE411030T1 (de) * 2004-04-14 2008-10-15 Gilead Sciences Inc Phosphonatanaloga von hiv- integrasehemmerverbindungen
ZA200804550B (en) 2005-11-09 2009-08-26 Combinatorx Inc Methods, compositions, and kits for the treatment of medical conditions
US8232402B2 (en) * 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
US20100331363A1 (en) * 2008-11-13 2010-12-30 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
US20110060005A1 (en) * 2008-11-13 2011-03-10 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
MX2011005096A (es) * 2008-11-13 2011-11-18 Link Medicine Corp Derivados de azaquinolinona y usos de los mismos.
HK1198762A1 (en) * 2011-07-25 2015-06-05 Allergan, Inc. N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US4029792A (en) * 1972-02-29 1977-06-14 Pfizer Inc. (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
US4036976A (en) * 1973-04-05 1977-07-19 Sandoz, Inc. Substituted imidazolinylamino-indazoles
US4217356A (en) * 1975-08-22 1980-08-12 Sandoz Ltd. 2-Imidazolinylamino-2,1,3-benzothiadiazoles
US4398028A (en) * 1977-01-14 1983-08-09 Sandoz Ltd. Bicyclic heterocyclic amino derivatives
EP0025269B1 (en) * 1979-08-23 1985-11-13 Beecham Group Plc Anti-diarrhoea veterinary composition
US4436913A (en) * 1980-09-05 1984-03-13 Siegfried Aktiengesellschaft 1H- and 2H- indazole derivatives
FR2638356A1 (fr) * 1988-10-28 1990-05-04 Anben Nouveaux derives de la 2-arylimino-imidazolidine pour diminuer la pression intra-oculaire et traiter le glaucome
US5021410A (en) * 1989-05-22 1991-06-04 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5180721A (en) * 1989-05-22 1993-01-19 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5281591A (en) * 1989-05-22 1994-01-25 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5231096A (en) * 1989-10-12 1993-07-27 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
US5021416A (en) * 1989-10-31 1991-06-04 Allergan, Inc. Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents

Also Published As

Publication number Publication date
SK77096A3 (en) 1997-02-05
HK1013072A1 (en) 1999-08-13
NO308662B1 (no) 2000-10-09
NZ333370A (en) 2001-03-30
CZ285481B6 (cs) 1999-08-11
US5739148A (en) 1998-04-14
HUT76277A (en) 1997-07-28
FI962491A0 (fi) 1996-06-14
DK0736020T3 (da) 2000-08-07
NO962536D0 (no) 1996-06-14
DE69424183D1 (de) 2000-05-31
DE69424183T2 (de) 2001-02-15
SG55141A1 (en) 1998-12-21
ATE192150T1 (de) 2000-05-15
PT736020E (pt) 2000-10-31
CA2179264C (en) 1999-05-18
WO1995016683A1 (en) 1995-06-22
EP0736020B1 (en) 2000-04-26
FI962491L (fi) 1996-07-26
FI962491A7 (fi) 1996-07-26
ES2146307T3 (es) 2000-08-01
PL180392B1 (pl) 2001-01-31
NO962536L (no) 1996-08-02
HU9601659D0 (en) 1996-08-28
AU699041B2 (en) 1998-11-19
PL315060A1 (en) 1996-09-30
GR3033515T3 (en) 2000-09-29
JPH09511483A (ja) 1997-11-18
AU1306395A (en) 1995-07-03
CZ175396A3 (en) 1996-11-13
HU217841B (hu) 2000-04-28
CA2179264A1 (en) 1995-06-22
EP0736020A1 (en) 1996-10-09
CN1137793A (zh) 1996-12-11
CN1046718C (zh) 1999-11-24

Similar Documents

Publication Publication Date Title
NO962539L (no) 5-(2-imidazolinylamino)benzimidazol-derivater, deres fremstilling og deres anvendelse som -2-adreniceptor-agonister
BR9303993A (pt) Composto, processo para preparar o mesmo e composição farmacêutica
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
BR0202397A (pt) Composição, utilização da mesma, processo de tratamento cosmético, e, utilização de pelo menos um éster n-acilado de aminoácido
FI962491A0 (fi) Alpha-2-adrenoseptoriagonisteina käyttökelpoisia 6-(2-imidatsolinyyliamino)kinolinyyliyhdisteitä
MY133473A (en) Haterocyclic glycyl beta-alanine derivatives.
KR960006915A (ko) 췌장염의 치료 조성물
ATE25241T1 (de) Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
DE69309454D1 (de) Pyridincarboximidamide und deren anwendung
FI920435A0 (fi) N-(aryloxyalkyl) heteroaryl-8 -azabicyclo/3.2.1./oktaner, mellanprodukter och deras framstaellnings -foerfarande och deras anvaendning som laekemedel.
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
BR9912706A (pt) Composições farmacêuticas contendo ibuprofeno e domperidona
BR9807330A (pt) Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo
DE69827614D1 (de) Chinoxalindionen
KR910000150A (ko) 대사성 골 질환 치료제
BR9911574A (pt) Ciclooctadepsipeptìdeos substituìdos
BR0209065A (pt) Sulfato de composto de cefemo
BR9915441A (pt) Compostos funcionais de carbamato particulado e revestimentos em pó compreendendo os mesmos
TW333529B (en) Substituted heterocycloalkenes
TH25498A (th) สารประกอบเบนโซไธโอฟีน,สารขั้นกลาง,องค์ประกอบและวิธี

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal